Patients with existing heart or kidney disease may benefit from starting SGLT-2 inhibitors therapy, while those with a higher risk of developing these conditions, such as obese patients and those with no cardiogenic stroke, may benefit more from GLP-1 RAs
The first is what a PharmacoEconomics study found in August 2024: total estimated Medicare Part D savings were $8.6 billion using 90-day CostPlusDrugs.com pricing, with surgical drugs accounting for over $900 million
Some common side effects you may experience while using semaglutide injection include nausea, vomiting, diarrhea or constipation, heartburn, and abdominal pain
If you encounter any of these symptoms, it's best to consult with a healthcare professional to determine the appropriate course of action
Z71.3 Dietary counseling and surveillance This code is used to report encounters where dietary advice and monitoring are provided to patients aiming for weight loss or managing nutritional issues
